Literature DB >> 8870380

Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia.

D Scribano1, S Baroni, L Pagano, C Zuppi, G Leone, B Giardina.   

Abstract

In the present work we investigated HDL-C and its subfractions HDL2 and HDL3 as well as total cholesterol (TC), triglycerides (TG), LDL-C, VLDL-C, apolipoproteins A1 (ApoA1) and B (ApoB) and lipoprotein (a) (Lp(a) in 25 patients with newly diagnosed acute lymphocytic leukemia (ALL) before and after induction treatment. The mean basal plasma levels of TC, HDL-C and its subfractions, LDL-C, and ApoA1 were significantly lower than the mean values observed in normal subjects, whereas TG and VLDL-C were significantly higher. The patients (n = 22) who achieved complete remission after chemotherapy showed a significant increase of TC, HDL-C, HDL2, HDL3, ApoA1 and a significant decrease of TG and VLDL-C. These data suggest that ALL patients are characterized by a lipid metabolic derangement mainly of HDL and TG-rich lipoproteins, that is reversed by effective treatment of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870380

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  10 in total

1.  Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.

Authors:  Feng Su; Kathy R Kozak; Satoshi Imaizumi; Feng Gao; Malaika W Amneus; Victor Grijalva; Carey Ng; Alan Wagner; Greg Hough; Gina Farias-Eisner; G M Anantharamaiah; Brian J Van Lenten; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

2.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger
Journal:  Eur J Cancer       Date:  2014-07-30       Impact factor: 9.162

Review 3.  Apolipoprotein A-I: A Molecule of Diverse Function.

Authors:  Manaswini Mangaraj; Rachita Nanda; Suchismita Panda
Journal:  Indian J Clin Biochem       Date:  2015-07-16

Review 4.  Targeted nanoparticles for pediatric leukemia therapy.

Authors:  Riyaz Basha; Nirupama Sabnis; Kenneth Heym; W Paul Bowman; Andras G Lacko
Journal:  Front Oncol       Date:  2014-05-13       Impact factor: 6.244

5.  Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma.

Authors:  Yang Lv; Li-Yun Miao; Qiu-Fang Chen; Yan Li; Zhi-Xiang Shi; Xuan-Sheng Ding
Journal:  Onco Targets Ther       Date:  2016-01-22       Impact factor: 4.147

6.  Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.

Authors:  Pernille Rudebeck Mogensen; Kathrine Grell; Kjeld Schmiegelow; Ulrik Malthe Overgaard; Benjamin Ole Wolthers; Signe Sloth Mogensen; Allan Vaag; Thomas Leth Frandsen
Journal:  PLoS One       Date:  2020-04-06       Impact factor: 3.240

7.  Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia.

Authors:  Jianai Sun; Yinjun Lou; Jingjing Zhu; Huafei Shen; Lixia Zhu; Xiudi Yang; Mixue Xie; Li Li; Xianbo Huang; Mingyu Zhu; Yanlong Zheng; Wanzhuo Xie; Xiujin Ye; Jie Jin; Hong-Hu Zhu
Journal:  Front Oncol       Date:  2020-11-25       Impact factor: 6.244

8.  Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia.

Authors:  Xiaoya Yun; Xiang Sun; Xinting Hu; Huimin Zhang; Zixun Yin; Xin Zhang; Ming Liu; Ya Zhang; Xin Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.

Authors:  Maria Braoudaki; George I Lambrou; Konstantinos Vougas; Kalliopi Karamolegou; George T Tsangaris; Fotini Tzortzatou-Stathopoulou
Journal:  J Hematol Oncol       Date:  2013-07-12       Impact factor: 17.388

10.  Lipid changes occuring in the course of hematological cancers.

Authors:  Małgorzata Kuliszkiewicz-Janus; Rafał Małecki; Abdulrahman Saeed Mohamed
Journal:  Cell Mol Biol Lett       Date:  2008-05-06       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.